RecallWatchUSA

Home / Recalls / Drugs

PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls Nystatin Oral Suspension, USP, 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl oz (473 mL) bottle, Rx ONLY, pai Ph

Recalled April 1, 2020 · FDA recall D-1060-2020 · PAI Holdings, LLC.

Hazard
SubPotent Drug: Low out-of-specification results for assay testing. · FDA Class II
Units
7416 bottles
Sold at
Nationwide in the USA.

Description

SubPotent Drug: Low out-of-specification results for assay testing.

Product
Nystatin Oral Suspension, USP, 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl oz (473 mL) bottle, Rx ONLY, pai Pharmaceutical Associates, Inc., Greenville, SC 29605; NDC 0121-0810-16.
Manufacturer(s)
PAI Holdings, LLC. dba Pharmaceutical Associates Inc

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov

PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls Nystatin Oral Suspension, USP, 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl oz (473 mL) bottle, Rx ONLY, pai Ph | RecallWatchUSA